Structure via PubChem · Public domain (PubChem)
memantine
Sign in to saveAlso known as 3,5-dimethyl-1-adamantanamine, 1,3-dimethyl-5-adamantanamine, 3,5-dimethyl-1-aminoadamantane, 3,5-dimethyltricyclo[3.3.1.1(3,7)]decan-1-amine, 1-amino-3,5-dimethyladamantane, 1,3-dimethylaminoadamantane
Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. It is taken by mouth.
Chemical data
- Formula
- C12H21N
- Molecular weight
- 179.3 g/mol
- IUPAC name
- 3,5-dimethyladamantan-1-amine
- SMILES
- CC12CC3CC(C1)(CC(C3)(C2)N)C
- InChIKey
- BUGYDGFZZOZRHP-UHFFFAOYSA-N
- XLogP
- 3.3
- Polar surface area
- 26 Ų
- H-bond donors
- 1
- H-bond acceptors
- 1
- Formal charge
- 0
via PubChem
Research
5,145 papers- Mechanism of action of memantine.Current opinion in pharmacology · 2006
- Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias.Ideggyogyaszati szemle · 2021
- Memantine.Drugs & aging · 2003
- Memantine: Updating a rare success story in pro-cognitive therapeutics.Neuropharmacology · 2024
- Memantine Derivatives as Multitarget Agents in Alzheimer's Disease.Molecules (Basel, Switzerland) · 2020
via PubMed
Described at

Memantine: a medicine to treat some types of dementia. - NHS
NHS medicines information on memantine – what it's used for, side effects, dosage and who can take it.
nhs.uk →Link to a page describing this subject · 2,355 chars · not written by Vinony
Wikidata facts
- Mass
- 179.1674
Show 6 more facts
- Commons category
- Memantine
- chemical formula
- C₁₂H₂₁N
- canonical SMILES
- CC12CC3CC(C1)(CC(C3)(C2)N)C
- World Health Organisation international non-proprietary name
- memantine
- defined daily dose
- 40
- described at URL
- www.healthline.com/health/drugs/memantine-oral-tablet
Sources (7)
via Wikidata · CC0
~19 min read
Article
31 sectionsContents
- Medical uses
- Alzheimer's disease and dementia
- Radiation therapy
- Adverse effects
- Pharmacology
- Pharmacodynamics
- Glutamatergic
- Serotonergic
- Cholinergic
- Dopaminergic
- Sigmaergic
- Other actions
- Pharmacokinetics
- Absorption
- Distribution
- Metabolism
- Elimination
- Chemistry
- History
- Society and culture
- Recreational use
- Brand names
- Research
- Psychiatric disorders
- Parkinson's disease
- Apathy
- Long COVID
- Catatonia
- Autism spectrum disorder
- References
- Further reading
Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. It is taken by mouth.
Common side effects include headache, constipation, sleepiness, and dizziness. Severe side effects may include blood clots, psychosis, and heart failure. It is believed to work by acting on NMDA receptors, working as a pore blocker of these ion channels.